Pillar Pacific Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-12,030
| Closed | -$206K | – | 302 |
|
|
2018
Q1 | $206K | Sell |
12,030
-250
| -2% | -$4.28K | 0.02% | 277 |
|
|
2017
Q4 | $233K | Sell |
12,280
-29,042
| -70% | -$551K | 0.03% | 268 |
|
|
2017
Q3 | $727K | Sell |
41,322
-52,691
| -56% | -$927K | 0.09% | 149 |
|
|
2017
Q2 | $3.12M | Buy |
94,013
+2,325
| +3% | +$77.2K | 0.43% | 98 |
|
|
2017
Q1 | $2.94M | Buy |
91,688
+8,359
| +10% | +$268K | 0.42% | 100 |
|
|
2016
Q4 | $3.02M | Buy |
83,329
+1,975
| +2% | +$71.6K | 0.47% | 94 |
|
|
2016
Q3 | $3.74M | Buy |
81,354
+2,285
| +3% | +$105K | 0.59% | 78 |
|
|
2016
Q2 | $3.97M | Buy |
79,069
+3,873
| +5% | +$195K | 0.67% | 65 |
|
|
2016
Q1 | $4.02M | Buy |
75,196
+3,095
| +4% | +$166K | 0.7% | 60 |
|
|
2015
Q4 | $4.73M | Buy |
72,101
+2,341
| +3% | +$154K | 0.85% | 41 |
|
|
2015
Q3 | $3.94M | Buy |
69,760
+1,228
| +2% | +$69.3K | 0.74% | 55 |
|
|
2015
Q2 | $4.05M | Buy |
68,532
+2,940
| +4% | +$174K | 0.7% | 66 |
|
|
2015
Q1 | $4.09M | Buy |
65,592
+3,905
| +6% | +$243K | 0.72% | 64 |
|
|
2014
Q4 | $3.55M | Buy |
61,687
+757
| +1% | +$43.5K | 0.64% | 73 |
|
|
2014
Q3 | $3.28M | Buy |
60,930
+2,155
| +4% | +$116K | 0.6% | 77 |
|
|
2014
Q2 | $3.08M | Buy |
58,775
+3,890
| +7% | +$204K | 0.58% | 79 |
|
|
2014
Q1 | $2.9M | Sell |
54,885
-475
| -0.9% | -$25.1K | 0.59% | 79 |
|
|
2013
Q4 | $2.22M | Buy |
55,360
+84
| +0.2% | +$3.37K | 0.44% | 92 |
|
|
2013
Q3 | $2.09M | Buy |
55,276
+4,051
| +8% | +$153K | 0.46% | 94 |
|
|
2013
Q2 | $2.01M | Buy |
+51,225
| New | +$2.01M | 0.48% | 90 |
|